ZP SPV 3 K/S: Financial statements 2020
CVR: 41038039
Source: annual report 2020, Danish Business Authority
09/12/2019 – 31/12/2020
ZP SPV 3 K/S (CVR 41038039) has filed annual accounts for 2020. In 2020, the company reported revenue of USD 1,300 and a net result of USD -118. The profit margin was -9.1%. Equity in the 2020 report amounted to USD 5,765. The solvency ratio was 77%.
- Revenue
- USD 1,300
- Gross Profit
- USD 1,300
- Profit/Loss
- USD -118
- Equity
- USD 5,765
- Total Assets
- USD 7,488
Official annual report
How creditworthy is ZP SPV 3 K/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout ZP SPV 3 K/S
ZP SPV 3 K/S is a Danish company of the type Kommanditselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of ZP General Partner 3 ApS. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,039,000 compared with DKK -34,739,000 the year before. Equity in the 2025 report amounted to DKK 429,000.